← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Galenea Corporation
Cambridge, MA
$6,868,846
Total funding
4
Grants
Funding over time
peak $5M · FY2009–16$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$9,536,834 · 5
By mechanism
RC4$4,484,789 · 1
R01$2,667,988 · 1
R43$1,320,446 · 2
RC1$1,063,611 · 1
Investigators at Galenea Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
Mechanism-based, pro-cognitive therapies for schizophrenia$4,484,789
RC4 · FY2010 · MH
Electrophysiological Endophenotypes of Schizophrenia in Mouse and Man$625,924
R01 · FY2012 · MH
Electrophysiological Endophenotypes of Schizophrenia in Mouse and Man$576,919
R01 · FY2015 · MH
Electrophysiological Endophenotypes of Schizophrenia in Mouse and Man$575,438
R01 · FY2013 · MH
Electrophysiological Endophenotypes of Schizophrenia in Mouse and Man$563,678
R01 · FY2014 · MH
In vivo methods for preclinical analysis of cognitive therapies for schizophrenia$533,641
RC1 · FY2010 · MH
In vivo methods for preclinical analysis of cognitive therapies for schizophrenia$529,970
RC1 · FY2009 · MH
Novel serotonergic, pro-cognitive antipsychotic therapies$349,802
R43 · FY2011 · MH
Novel serotonergic, pro-cognitive antipsychotic therapies$346,141
R43 · FY2012 · MH
Electrophysiological Endophenotypes of Schizophrenia in Mouse and Man$326,029
R01 · FY2016 · MH
In vitro tools for preclinical analysis of cognitive therapies for schizophrenia$312,853
R43 · FY2012 · MH
In vitro tools for preclinical analysis of cognitive therapies for schizophrenia$311,650
R43 · FY2011 · MH